Fundraising FoxErlysign
Nagpur, IN · 1 known investors
Find your way into Erlysign
Sign up to see every warm intro you have to Erlysign
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Erlysign team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ErlySign, operated by CURO Biosciences, develops a non-invasive, saliva-based biomarker test kit that screens for oral precancerous conditions within about 15 minutes. The product targets hospitals, clinics, labs, and distributors for early cancer detection, with a focus on the Indian market.
Investors · 1
Frequently asked questions
- What does Erlysign do?
- ErlySign, operated by CURO Biosciences, develops a non-invasive, saliva-based biomarker test kit that screens for oral precancerous conditions within about 15 minutes. The product targets hospitals, clinics, labs, and distributors for early cancer detection, with a focus on the Indian market.
- Who are Erlysign's investors?
- Erlysign's investors include Anthill Ventures.
- Where is Erlysign headquartered?
- Erlysign is headquartered in Nagpur, IN.